Ma W - Search Results

1

BRCA1 mRNA expression modifies the effect of T cell activation score on patient survival in breast cancer.

Lu L, Huang H, Zhou J, Ma W, Mackay S, Wang Z. Lu L, et al. Among authors: ma w. BMC Cancer. 2019 Apr 25;19(1):387. doi: 10.1186/s12885-019-5595-3. BMC Cancer. 2019. PMID: 31023256 Free PMC article.

2

Circulating tumor cell clusters-associated gene plakoglobin and breast cancer survival.

Lu L, Zeng H, Gu X, Ma W. Lu L, et al. Among authors: ma w. Breast Cancer Res Treat. 2015 Jun;151(3):491-500. doi: 10.1007/s10549-015-3416-1. Epub 2015 May 10. Breast Cancer Res Treat. 2015. PMID: 25957595 Review.

3

IFNγ enhances cytotoxic efficiency of the cytotoxic T lymphocytes against human glioma cells.

Shao S, Risch E, Burner D, Lu L, Minev B, Ma W. Shao S, et al. Among authors: ma w. Int Immunopharmacol. 2017 Jun;47:159-165. doi: 10.1016/j.intimp.2017.04.003. Epub 2017 Apr 12. Int Immunopharmacol. 2017. PMID: 28410529

4

Artificial human antigen-presenting cells are superior to dendritic cells at inducing cytotoxic T-cell responses.

Li H, Shao S, Cai J, Burner D, Lu L, Chen Q, Minev B, Ma W. Li H, et al. Among authors: ma w. Immunology. 2017 Nov;152(3):462-471. doi: 10.1111/imm.12783. Epub 2017 Jul 27. Immunology. 2017. PMID: 28664991 Free PMC article.

5

Epithelial membrane protein 2: a novel biomarker for circulating tumor cell recovery in breast cancer.

Chen Q, Yao L, Burner D, Minev B, Lu L, Wang M, Ma W. Chen Q, et al. Among authors: ma w. Clin Transl Oncol. 2019 Apr;21(4):433-442. doi: 10.1007/s12094-018-1941-1. Epub 2018 Sep 14. Clin Transl Oncol. 2019. PMID: 30218306

6

Factors affecting tumor responders and predictive biomarkers of toxicities in cancer patients treated with immune checkpoint inhibitors.

Yao L, Jia G, Lu L, Bao Y, Ma W. Yao L, et al. Among authors: ma w. Int Immunopharmacol. 2020 Aug;85:106628. doi: 10.1016/j.intimp.2020.106628. Epub 2020 May 28. Int Immunopharmacol. 2020. PMID: 32474388 Review.

7

Immunopathological changes, complications, sequelae and immunological memory in COVID-19 patients.

Yao L, Lu L, Ma W. Yao L, et al. Among authors: ma w. Heliyon. 2022 Apr;8(4):e09302. doi: 10.1016/j.heliyon.2022.e09302. Epub 2022 Apr 26. Heliyon. 2022. PMID: 35497026 Free PMC article. Review.

8

Breast Cancer Patients: Who Would Benefit from Neoadjuvant Chemotherapies?

Yao L, Jia G, Lu L, Ma W. Yao L, et al. Among authors: ma w. Curr Oncol. 2022 Jul 12;29(7):4902-4913. doi: 10.3390/curroncol29070389. Curr Oncol. 2022. PMID: 35877249 Free PMC article. Review.

9

Efficacy, Safety, and Challenges of CAR T-Cells in the Treatment of Solid Tumors.

Chen Q, Lu L, Ma W. Chen Q, et al. Among authors: ma w. Cancers (Basel). 2022 Dec 3;14(23):5983. doi: 10.3390/cancers14235983. Cancers (Basel). 2022. PMID: 36497465 Free PMC article. Review.

10

Tumor growth inhibition by mSTEAP peptide nanovaccine inducing augmented CD8⁺ T cell immune responses.

Chen Q, Bao Y, Burner D, Kaushal S, Zhang Y, Mendoza T, Bouvet M, Ozkan C, Minev B, Ma W. Chen Q, et al. Among authors: ma w. Drug Deliv Transl Res. 2019 Dec;9(6):1095-1105. doi: 10.1007/s13346-019-00652-z. Drug Deliv Transl Res. 2019. PMID: 31228097

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

13,554 results

Search Page

Filters